BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19743415)

  • 1. Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells.
    Cao J; Hu Y; Shen C; Yao J; Wei L; Yang F; Nie A; Wang H; Shen H; Liu Y; Zhang Y; Tang Y; Yang P
    Proteomics; 2009 Nov; 9(21):4881-8. PubMed ID: 19743415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.
    Mbeunkui F; Fodstad O; Pannell LK
    J Proteome Res; 2006 Apr; 5(4):899-906. PubMed ID: 16602697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.
    Cao J; Shen C; Wang H; Shen H; Chen Y; Nie A; Yan G; Lu H; Liu Y; Yang P
    J Proteome Res; 2009 Feb; 8(2):662-72. PubMed ID: 19196183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An iTRAQ based quantitative proteomic strategy to explore novel secreted proteins in metastatic hepatocellular carcinoma cell lines.
    Yu Y; Pan X; Ding Y; Liu X; Tang H; Shen C; Shen H; Yang P
    Analyst; 2013 Aug; 138(16):4505-11. PubMed ID: 23752568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry.
    Wu HY; Chang YH; Chang YC; Liao PC
    J Proteome Res; 2009 Jan; 8(1):380-9. PubMed ID: 19012429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of alternative extraction methods for secretome profiling in human hepatocellular carcinoma cells.
    Cao J; Shen C; Zhang J; Yao J; Shen H; Liu Y; Lu H; Yang P
    Sci China Life Sci; 2011 Jan; 54(1):34-8. PubMed ID: 21253868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel technique to specifically analyze the secretome of cells and tissues.
    Zwickl H; Traxler E; Staettner S; Parzefall W; Grasl-Kraupp B; Karner J; Schulte-Hermann R; Gerner C
    Electrophoresis; 2005 Jul; 26(14):2779-85. PubMed ID: 15966010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin capture strategy for effective analysis of cell secretome.
    Zhang Y; Tang X; Yao L; Chen K; Jia W; Hu X; Xu LX
    Proteomics; 2012 Jan; 12(1):32-6. PubMed ID: 22065611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed proteomic reactor for the processing of proteomic samples.
    Hou W; Ethier M; Smith JC; Sheng Y; Figeys D
    Anal Chem; 2007 Jan; 79(1):39-44. PubMed ID: 17194119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using enrichment index for quality control of secretory protein sample and identification of secretory proteins.
    Chen Y; Gu B; Wu S; Sun W; Ma S; Liu Y; Gao Y
    J Mass Spectrom; 2009 Mar; 44(3):397-403. PubMed ID: 19003795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protein digestion through the confinement of nanozeolite-assembled microchip reactors.
    Ji J; Zhang Y; Zhou X; Kong J; Tang Y; Liu B
    Anal Chem; 2008 Apr; 80(7):2457-63. PubMed ID: 18321132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen.
    Lee HJ; Na K; Kwon MS; Kim H; Kim KS; Paik YK
    Proteomics; 2009 Jun; 9(12):3395-408. PubMed ID: 19562805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a better analysis of secreted proteins: the example of the myeloid cells secretome.
    Chevallet M; Diemer H; Van Dorssealer A; Villiers C; Rabilloud T
    Proteomics; 2007 Jun; 7(11):1757-70. PubMed ID: 17464941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic analysis of the insulin-induced L6 myotube secretome.
    Yoon JH; Yea K; Kim J; Choi YS; Park S; Lee H; Lee CS; Suh PG; Ryu SH
    Proteomics; 2009 Jan; 9(1):51-60. PubMed ID: 19053084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes.
    Lawlor K; Nazarian A; Lacomis L; Tempst P; Villanueva J
    J Proteome Res; 2009 Mar; 8(3):1489-503. PubMed ID: 19199430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concanavalin A-immobilized magnetic nanoparticles for selective enrichment of glycoproteins and application to glycoproteomics in hepatocelluar carcinoma cell line.
    Tang J; Liu Y; Yin P; Yao G; Yan G; Deng C; Zhang X
    Proteomics; 2010 May; 10(10):2000-14. PubMed ID: 20217867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to the study of the cell secretome.
    Hathout Y
    Expert Rev Proteomics; 2007 Apr; 4(2):239-48. PubMed ID: 17425459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
    Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma.
    Staab CA; Ceder R; Jägerbrink T; Nilsson JA; Roberg K; Jörnvall H; Höög JO; Grafström RC
    J Proteome Res; 2007 Sep; 6(9):3705-17. PubMed ID: 17696463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.